Abstract
Wound infections delay and may even prevent wound healing. Management of wound infection cannot be overstated for successful wound healing. To properly manage wound infections, there must first be accurate diagnosis as to what constitutes an infected wound. Various diagnostic methods for wound infection are presented in this chapter. After identifying the offending organism, the physician must determine the most appropriate intervention to reduce the wound’s bioburden. Available options include antimicrobial therapy, debridement, and adjunctive therapies. Debridement plays a vital role in the management of wound infections. Debridement of necrotic tissue and exudate helps to reduce wound bioburden and may also increase the effectiveness of topical antimicrobials and antibiotics. There are six primary types of debridements: autolytic, enzymatic, biological, mechanical, sharp, and surgical debridements. Surgical debridement is required for severe infection including osteomyelitis or sepsis and is usually followed by a course of antibiotics. Details of each debridement are described in this chapter. Biofilm is a relatively new concept in the fields of wound infection and healing. Although scientific research regarding wound biofilm is increasing, little is known about the effective management strategies. The author’s method to treat the wound biofilm is presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Alvarez OM, Fernandez-Obregon A, Rogers RS, et al. A prospective, randomized, comparative study of collagenase and papain-urea for pressure ulcer debridement. Wounds. 2002;14:293–301.
Andrew JM, Boulton MD, Kirsner RS, et al. Neuropathic diabetic foot ulcers. N Engl J Med. 2004;351:48–55.
Armstrong DG, Lipsky BA. Advances in the treatment of diabetic foot infections. Diabetes Technol Ther. 2004;6:167–77.
Attinger CE, Janis JE, Steinberg J, et al. Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg. 2006;117:72S–109.
Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14:244–69.
Brem H, Sheehan P, Rosenberg HJ, et al. Evidence-based protocol for diabetic foot ulcers. Plast Reconstr Surg. 2006;117:193S–209.
Broughton 2nd G, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006;117:12S–34.
Crane M, Werber B. Critical pathway approach to diabetic pedal infections in a multidisciplinary setting. J Foot Ankle Surg. 1999;38:30–3.
Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin-resistant staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med. 2002;20:159–61.
Dargis V, Pantelejeva O, Jonushaite A, et al. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulcerantion in Lithunania: a prospective study. Diabetes Care. 1999;22:1428–31.
Debats IB, Booi D, Deutz NE, et al. Infected chronic wounds show different local and systemic arginine conversion compared with acute wounds. J Surg Res. 2006;134:205–14.
Demling RH, Desanti RN. Effects of silver on wound management. Wounds. 2001;13:1–15.
Dogra S, Kumar B, Bhansali A, Chakrabarty A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol. 2002;41:647–51.
Ebright JR, Fairfax MR, Vazquezl JA. Trichosporonasahii, a non-candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin Infect Dis. 2001;33:28–30.
Ecemis T, Deqerli K, Aktas E, et al. The necessity of culture for the diagnosis of tineapedis. Am J Med Sci. 2006;331:88–90.
Edmonds M, Foster A. The use of antibiotics in the diabetic foot. Am J Surg. 2004;187:25S–8.
Emsen IM. Fatal side effect of maggot treatment on wound healing. Plast Reconstr Surg. 2007;119:1624.
Enoch S, Harding K. Wound bed preparation: the science behind the removal of barriers to healing. Part 1. Wounds. 2003;15:213.
Enoch S, Grey JE, Harding KG. ABC of wound healing. Non-surgical and drug treatments. BMJ. 2006;332:900–3.
Ethuin F, Gérard B, Benna JE, et al. Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab Invest. 2004;84:1363–71.
Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen. 2000;8:347–52.
Fivenson DP, Faria DT, Nickoloff BJ. Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Repair Regen. 1997;5:310–22.
Fleck CA. Identifying infection in chronic wounds. Adv Skin Wound Care. 2006;19:20–1.
Fowler EM, Vesely N, Johnson V, et al. Wound care for patients with diabetes. Adv Skin Wound Care. 2003;16:342–6.
Frykberg RG. Diabetic foot ulcer: pathogenesis and management. Am Fam Physician. 2002;66:1655–62.
Granick MS, Jacoby M, Noruthrun S, et al. Clinical and economic impact of hydro surgical debridement on chronic wounds. Wounds. 2006;18:35–9.
Han SK. Advanced treatments of diabetic foot ulcers. Diabetes (Korean). 2004;171:69.
Han SK. Diagnosis of wound infection in diabetic patients. J Korean Wound Manag Soc. 2007;3:53.
Han SK, Lee BI, Kim WK. Microbiology of diabetic foot patients in Korea. J Korean Wound Manag Soc. 2007;3:19.
Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299:1149–57.
Husain TM, Kim DH. C-reactive protein and erythrocyte sedimentation rate in orthopaedics. The Univ Pa Orthop J. 2002;15:13–6.
Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet. 2003;361:1545–51.
Jones CE, Kennedy JP. Treatment options to manage wound biofilm. Adv Wound Care. 2012;1:120–6.
Kelley ST, Theisen U, Angenent LT, et al. Molecular analysis of shower curtain biofilm microbes. Appl Environ Microbiol. 2004;70:4187–92.
Krcmery V, Krupova I, Denning DW. Invasive yeast infections other than candida spp. in acute leukaemia. J Hosp Infect. 1999;41:181–94.
Lavery LA, Armstrong DG, Wunderlich RP, et al. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–8.
Lee JM, Han SK, Jeong SH, et al. Comparison of WBC, ESR, and CRP levels for diagnosis of diabetic foot infection. J Korean Soc Plast Reconst Surg. 2010;37(4):346–50.
Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol. 1999;26:267–76.
Lipsky BA. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev. 2004;20:S68–77.
Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol. 1992;26:408–10.
Mosti G, Mattaliano V. The debridement of chronic leg ulcers by means of a new, fluidjet-based device. Wounds. 2006;18:227–37.
Motta RN, Oliveira MM, Magalhães PS, et al. Plasmid-mediated extended-spectrum b-lactamase-producing strains of enterobacteriaceae isolated from diabetes foot infections in a brazilian diabetic center. Braz J Infect Dis. 2003;7:129–34.
O’Gorman C, McMullan R, Webb CH, Bedi A. Trichosporonasahii. Blood-stream infection in anon-cancer patient receiving antifungal therapy. Ulster Med J. 2006;75:226–7.
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13:513–21.
Percival SL Bowler P (2004) Understanding the effects of bacterial communities and biofilms on wound healing. World Wide Wounds.
Percival SL, Hill KE, Williams DW, et al. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen. 2012;20:647–57.
Prete PE. Growth effects of Phaenicasericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci. 1997;60:505–10.
Pryor KO, Lien CA, Fahey 3rd TJ, Goldstein PA. Supplemental oxygen and risk of surgical wound infection. JAMA. 2006;295:1642–3.
RagnarsonTennvall G, Apelqvist J. Prevention of diabetesrelated foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia. 2001;44:2077–87.
Ramsey SD, Newton K, Blougt D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–7.
Reiber GE. The epidemiology of diabetic foot problems. Diabet Med. 1996;13:S6–11.
Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22:157–62.
Schaper NC, Apelqvist J, Bakker K. The international consensus and practical goudelines on the management and prevention of the diabetic foot. Curr Diad Rep. 2003;3:475–9.
Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11:S1–28.
Senneville E, Yazdanpanah Y, Cazaubiel M, et al. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother. 2001;48:927–30.
Tennvall GR, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomis. 2000;18:225–38.
Thomas S, Andrews AM, Hay NP, Bourgoise S. The anti-microbial activity of maggot secretions: results of a preliminary study. J Tissue Viability. 1999;9:127–32.
Todd WF, Armstrong DG, Liswood PJ. Evaluation and treatment of the infected foot in a community teaching hospital. J Am Podiatr Med Assoc. 1996;86:421–6.
Wieman TJ. Principles of management: the diabetic foot. Am J Surg. 2005;190:295–9.
Williams DT, Hilton JR, Harding KG. Diagnosing foot infection in diabetes. Clin Infect Dis. 2004;39:S83–6.
Wollina U, Karte K, Herold C, Looks A. Biosurgery in wound healing-the renaissance of maggot therapy. J Eur Acad Dermatol Venereol. 2000;14:285–9.
Younggren BN, Denny M. Emergency management of difficult wounds: Part II. Emerg Med Clin North Am. 2007;25:123–34.
Zacur H, Kirsner RS. Debridement: rationale and therapeutic options. Wounds. 2002;14:2S–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Han, SK. (2016). Infection, Debridement, and Biofilm. In: Innovations and Advances in Wound Healing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46587-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-46587-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46586-8
Online ISBN: 978-3-662-46587-5
eBook Packages: MedicineMedicine (R0)